Artificial pancreas using a personalized rule-based controller achieves overnight normoglycemia in patients with type 1 diabetes

Diabetes Technology and Therapeutics

Volumn 16, Issue 3, 2014, Pages 172-179

  Capel, Ismael ^a   Rigla, Mercedes ^a   García Sáez, Gema ^b,c   Rodríguez Herrero, Agustín ^c   Pons, Belén ^a   Subías, David ^a   García García, Fernando ^b,c   Gallach, Maria ^a   Aguilar, Montserrat ^a   Pérez Gandía, Carmen ^b,c   Gómez, Enrique J ^b,c   Caixàs, Assumpta ^a   Hernando, M Elena ^b,c  

^a Hospital Parc Tauli   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN ASPART; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ALGORITHM; ARTICLE; ARTIFICIAL PANCREAS; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE; MEAL; METABOLIC REGULATION; MIDDLE AGED; NIGHT; PERSONALIZED MEDICINE; POSTPRANDIAL STATE; PREDICTIVE RULE BASED ALGORITHM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; BLOOD; DIABETES MELLITUS, TYPE 1; METABOLISM; PATHOPHYSIOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; SUBCUTANEOUS DRUG ADMINISTRATION; TIME; TREATMENT OUTCOME;

ALGORITHMS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MEALS; PANCREAS, ARTIFICIAL; POSTPRANDIAL PERIOD; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84896848580     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0229     Document Type: Article

References (29)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
2. Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997;46:271-286.
3. van Belle TL, Coppieters KT, von Herrath MG: Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011;91:79-118.
4. Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH: Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med 2012; 157:336-347.
5. Bellazzi R, Nucci G, Cobelli C: The subcutaneous route to insulin-dependent diabetes therapy. IEEE Eng Med Biol Mag 2001;20:54-64.
6. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF: Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 2006;55:3344-3350.
7. O'Grady MJ, Retterath AJ, Keenan DB, Kurtz N, Cantwell M, Spital G, Kremliovsky MN, Roy A, Davis EA, Jones TW, Ly TT: The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes. Diabetes Care 2012;35: 2182-2187.
8. Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, Kollman C, Hovorka T, Larsen AM, Nodale M, De Palma A, Wilinska ME, Acerini CL, Dunger DB: Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010; 375:743-751.
9. Breton M, Farret A, Bruttomesso D, Anderson S, Magni L, Patek S, Dalla Man C, Place J, Demartini S, Del Favero S, Toffanin C, Hughes-Karvetski C, Dassau E, Zisser H, Doyle FJ 3rd, De Nicolao G, Avogaro A, Cobelli C, Renard E, Kovatchev B; International Artificial Pancreas Study Group: Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes 2012;61:2230-2237.
10. Rodríguez-Herrero A, Pérez-Gandía C, Rigla M, de Leiva A, Gómez EJ, Hernando ME: A simulation study of an inverse controller for closed- and semiclosed-loop control in type 1 diabetes. Diabetes Technol Ther 2010;12:95-104.
11. Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, Biester T, Stefanija MA, Muller I, Nimri R, Danne T: Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013;368:824-833.
12. Wang Y, Dassau E, Zisser H, Jovanovic L, Doyle FJ 3rd: Automatic bolus and adaptive basal algorithm for the artificial pancreatic b-cell. Diabetes Technol Ther 2010;12:879-887.
13. Elleri D, Allen JM, Kumareswaran K, Leelarathna L, Nodale M, Caldwell K, Cheng P, Kollman C, Haidar A, Murphy HR, Wilinska ME, Acerini CL, Dunger DB, Hovorka R: Closedloop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care 2013;36:838-844.
14. Renard E, Place J, Cantwell M, Chevassus H, Palerm CC: Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas. Diabetes Care 2010;33:121-127.
15. Atlas E, Nimri R, Miller S, Grunberg EA, Phillip M: MDLogic artificial pancreas system: a pilot study in adults with type 1 diabetes. Diabetes Care 2010;33:1072-1076.
16. Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B: Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabetes Sci Technol 2009;3:1031-1038.
17. Patek SD, Magni L, Dassau E, Karvetski C, Toffanin C, De Nicolao G, Del Favero S, Breton M, Man CD, Renard E, Zisser H, Doyle FJ 3rd, Cobelli C, Kovatchev BP; International Artificial Pancreas (iAP) Study Group: Modular closed-loop control of diabetes. IEEE Trans Biomed Eng 2012;59:2986-2999.
18. Pérez-Gandía C, Facchinetti A, Sparacino G, Cobelli C, Gómez EJ, Rigla M, de Leiva A, Hernando ME: Artificial neural network algorithm for online glucose prediction from continuous glucose monitoring. Diabetes Technol Ther 2010; 12:81-88.
19. Hovorka R, Canonico V, Chassin LJ, Haueter U, Massi- Benedetti M, Orsini Federici M, Pieber TR, Schaller HC, Schaupp L, Vering T, Wilinska ME: Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Meas 2004;25:905-920.
20. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young- Hyman D, Schlundt D, Clarke W: Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the Low Blood Glucose Index. Diabetes Care 1998; 21:1870-1875.
21. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622-628.
22. Kovatchev BP, Gonder-Frederick LA, Cox DJ, Clarke WL: Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care 2004;27: 1922-1928.
23. Magni L, Raimondo DM, Man CD, Breton M, Patek S, Nicolao GD, Cobelli C, Kovatchev BP: Evaluating the efficacy of closed-loop glucose regulation via control-variability grid analysis. J Diabetes Sci Technol 2008;2:630-635.
24. Kovatchev BP, Renard E, Cobelli C, Zisser HC, Keith-Hynes P, Anderson SM, Brown SA, Chernavvsky DR, Breton MD, Farret A, Pelletier MJ, Place J, Bruttomesso D, Del Favero S, Visentin R, Filippi A, Scotton R, Avogaro A, Doyle FJ 3rd: Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care 2013;36:1851-1858.
25. Nimri R, Danne T, Kordonouri O, Atlas E, Bratina N, Biester T, Avbelj M, Miller S, Muller I, Phillip M, Battelino T: The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial. Pediatr Diabetes 2013;14:159-167.
26. Dassau E, Cameron F, Lee H, Bequette BW, Zisser H, Jovanovic L, Chase HP, Wilson DM, Buckingham BA, Doyle FJ 3rd: Real-time hypoglycemia prediction suite using continuous glucose monitoring: a safety net for the artificial pancreas. Diabetes Care 2010;33:1249-1254.
27. Hellman B: Pulsatility of insulin release-a clinically important phenomenon. Ups J Med Sci 2009;114:193-205.
28. Wahren J, Kallas A: Loss of pulsatile insulin secretion: a factor in the pathogenesis of type 2 diabetes? Diabetes 2012;61:2228-2229.
29. Dassau E, Zisser H, Harvey RA, Percival MW, Grosman B, Bevier W, Atlas E, Miller S, Nimri R, Jovanovic L, Doyle FJ 3rd: Clinical evaluation of a personalized artificial pancreas. Diabetes Care 2013;36:801-809.